COURSE 1D - SUBSTANCE ABUSE: CLINICAL ISSUES IN INTENSIVE OUTPATIENT TREATMENT

Course overview

As with all courses sponsored by CEU By Net, this short 1-hour course meets the criteria of NBCC for length (number of words per credit hour). It is a summary report of the National Guideline for ''Substance Abuse: Clinical Issues in Intensive Outpatient Treatment" - Developed by the Substance Abuse and Mental Health Services Administration (SAMHSA) and Its Center for Substance Abuse Treatment (CSAT). It is published by U.S. Department of Health and Human Services' National Guidelines Clearinghouse. It's a 'Quiz Only' course on this website. CEU By Net sponsors the course, administers the quiz and awards the certificate for a passing score. THE GOALS OF THIS MINI-COURSE 1D: This 1-credit mini-course is a SUMMARY of a larger publication, which can be found at the URL provided on our website in the catalog, and as such, the GOALS of this mini-course are limited to obtaining an OVERVIEW of the major points which SAMHSA believes to be essential in assessing the relevance and appropriateness of - and setting up - an Intensive Outpatient Treatment program for persons with Substance Use Disorders. For EAP providers, this course provides a guideline for the development of referral resources for clients who require these services. The GOALS are as follows: 1. Review the key elements and principles of the continuum of care for Substance Abuse treatment. 2. Know which services are effective and APPROPRIATE treatment approaches, in IOT programs. 3. Know which services are the 'Core and Enhanced Services' recommended by SAMHSA-CSAT 4. Consideration of entry, engagement, and treatment issues. ACKNOWLEDGMENTS: SAMHSA is a branch of the U.S. Department of Health and Human Services. The article is published and accessed on the internet through the National Guideline Clearinghouse (NGC). The chair of the SAMHSA-CSAT work group which put this GUIDELINE together is Robert F. Forman, PhD (Chair), Clinical Scientist in Medical Affairs, Cambridge, Massachusetts (Formerly Senior Investigator, Treatment Research Institute, University of Pennsylvania School of Medicine).